528
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Using objective markers and imaging in the development of novel treatments of chronic pain

&
Pages 443-447 | Published online: 09 Jan 2014

References

  • Hill R. NK1 (substance P) receptor antagonists – why are they not analgesic in humans? Trends Pharmacol. Sci.21(7), 244–246 (2000).
  • Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything – large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain78(3), 209–216 (1998).
  • Okuse K. Pain signalling pathways: from cytokines to ion channels. Int. J. Biochem. Cell Biol.39(3), 490–496 (2007).
  • Schmelz M, Michael K, Weidner C et al. Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport11(3), 645–648 (2000).
  • Klede M, Clough G, Lischetzki G, Schmelz M. The effect of the nitric oxide synthase inhibitor N-nitro-L-arginine-methyl ester on neuropeptide-induced vasodilation and protein extravasation in human skin. J. Vasc. Res.40(2), 105–114 (2003).
  • Sauerstein K, Klede M, Hilliges M, Schmelz M. Electrically evoked neuropeptide release and neurogenic inflammation differ between rat and human skin. J. Physiol.529(3), 803–810 (2000).
  • Weidner C, Klede M, Rukwied R et al. Acute effects of substance P and calcitonin gene-related peptide in human skin – a microdialysis study. J. Invest. Dermatol.115(6), 1015–1020 (2000).
  • Klede M, Handwerker HO, Schmelz M. Central origin of secondary mechanical hyperalgesia. J. Neurophysiol.90(1), 353–359 (2003).
  • Koppert W, Dern SK, Sittl R et al. A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine. Anesthesiology95(2), 395–402 (2001).
  • Koppert W, Zeck S, Blunk JA et al. The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction. Anesth. Analg.89(6), 1521–1527 (1999).
  • Chizh B, Napolitano A, O’Donnell M et al. The TRPV1 antagonist SB705498 attenuates TRPV1 receptor-mediated activity and inhibits inflammatory hyperalgesia in humans: results from a Phase 1 study. J. Pain7(Suppl. 4), S42 (2006).
  • Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol. Clin.30(5), 263–288 (2000).
  • Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain9(4), 463–484 (2005).
  • Brooks JC, Tracey I. The insula: a multidimensional integration site for pain. Pain128(1–2), 1–2 (2007).
  • Frot M, Magnin M, Mauguiere F, Garcia-Larrea L. Human SII and posterior insula differently encode thermal laser stimuli. Cereb. Cortex17(3), 610–620 (2007).
  • Maihofner C, Herzner B, Otto HH. Secondary somatosensory cortex is important for the sensory-discriminative dimension of pain: a functional MRI study. Eur. J. Neurosci.23(5), 1377–1383 (2006).
  • Rogers R, Wise RG, Painter DJ, Longe SE, Tracey I. An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging. Anesthesiology100(2), 292–301 (2004).
  • Wise RG, Rogers R, Painter D et al. Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil. Neuroimage16(4), 999–1014 (2002).
  • Wise RG, Williams P, Tracey I. Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain. Neuropsychopharmacology29(3), 626–635 (2004).
  • Schweinhardt P, Glynn C, Brooks J et al. An fMRI study of cerebral processing of brush-evoked allodynia in neuropathic pain patients. Neuroimage32(1), 256–265 (2006).
  • Schweinhardt P, Lee M, Tracey I. Imaging pain in patients: is it meaningful? Curr. Opin. Neurol.19(4), 392–400 (2006).
  • Iannetti GD, Zambreanu L, Wise RG et al. Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc. Natl Acad. Sci. USA102(50), 18195–18200 (2005).
  • Zambreanu L, Wise RG, Brooks JC, Iannetti GD, Tracey I. A role for the brainstem in central sensitisation in humans. Evidence from functional magnetic resonance imaging. Pain114(3), 397–407 (2005).
  • Shafritz KM, Collins SH, Blumberg HP. The interaction of emotional and cognitive neural systems in emotionally guided response inhibition. Neuroimage31(1), 468–475 (2006).
  • Luks TL, Simpson GV. Preparatory deployment of attention to motion activates higher-order motion-processing brain regions. Neuroimage22(4), 1515–1522 (2004).
  • Nagai Y, Critchley HD, Featherstone E et al. Brain activity relating to the contingent negative variation: an fMRI investigation. Neuroimage21(4), 1232–1241 (2004).
  • Huettel SA, McCarthy G. What is odd in the oddball task? Prefrontal cortex is activated by dynamic changes in response strategy. Neuropsychologia42(3), 379–386 (2004).
  • Anderson AK, Christoff K, Panitz D, De Rosa E, Gabrieli JD. Neural correlates of the automatic processing of threat facial signals. J. Neurosci.23(13), 5627–5633 (2003).
  • Yarkoni T, Braver TS, Gray JR, Green L. Prefrontal brain activity predicts temporally extended decision-making behavior. J. Exp. Anal. Behav.84(3), 537–554 (2005).
  • Fairhurst M, Wiech K, Dunckley P, Tracey I. Anticipatory brainstem activity predicts neural processing of pain in humans. Pain128(1–2), 101–110 (2007).
  • Iannetti GD, Niazy RK, Wise RG et al. Simultaneous recording of laser-evoked brain potentials and continuous, high-field functional magnetic resonance imaging in humans. Neuroimage28(3), 708–719 (2005).
  • Borsook D, Burstein R, Moulton E, Becerra L. Functional imaging of the trigeminal system: applications to migraine pathophysiology. Headache46(Suppl. 1), S32–S38 (2006).
  • Borsook D, Burstein R, Becerra L. Functional imaging of the human trigeminal system: opportunities for new insights into pain processing in health and disease. J. Neurobiol.61(1), 107–125 (2004).
  • Borsook D, DaSilva AFM, Ploghaus A, Becerra LR. Specific and somatotopic functional magnetic resonance imaging activation in the trigeminal ganglion by brush and noxious heat. J. Neurosci.23(21), 7897–7903 (2003).
  • DaSilva AFM, Becerra L, Markis N et al. Somatotopic activation in the human trigeminal pain pathway. J. Neurosci.22(18), 8183–8192 (2002).
  • Becerra L, Morris S, Bazes S et al. Trigeminal neuropathic pain alters responses in CNS circuits to mechanical (brush) and thermal (cold and heat) stimuli. J. Neurosci.26(42), 10646–10657 (2006).
  • Foss JM, Apkarian AV, Chialvo DR. Dynamics of pain: fractal dimension of temporal variability of spontaneous pain differentiates between pain states. J. Neurophysiol.95(2), 730–736 (2006).
  • Geha PY, Baliki MN, Chialvo DR et al. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain128(1–2), 88–100 (2007).
  • Baliki MN, Chialvo DR, Geha PY et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J. Neurosci.26(47), 12165–12173 (2006).
  • Chen AC. New perspectives in EEG/MEG brain mapping and PET/fMRI neuroimaging of human pain. Int. J. Psychophysiol.42(2), 147–159 (2001).
  • Lorenz J, Garcia-Larrea L. Contribution of attentional and cognitive factors to laser evoked brain potentials. Neurophysiol. Clin.33(6), 293–301 (2003).
  • Kakigi R, Inui K, Tamura Y. Electrophysiological studies on human pain perception. Clin. Neurophysiol.116(4), 743–763 (2005).
  • Garcia-Larrea L, Frot M, Valeriani M. Brain generators of laser-evoked potentials: from dipoles to functional significance. Neurophysiol. Clin.33(6), 279–292 (2003).
  • Hauck M, Bischoff P, Schmidt G et al. Clonidine effects on pain evoked SII activity in humans. Eur. J. Pain10(8), 757–765 (2006).
  • Larbig W, Montoya P, Braun C, Birbaumer N. Abnormal reactivity of the primary somatosensory cortex during the experience of pain in complex regional pain syndrome: a magnetoencephalograhic case study. Neurocase12(5), 280–285 (2006).
  • Ploner M, Gross J, Timmermann L, Pollok B, Schnitzler A. Pain suppresses spontaneous brain rhythms. Cereb. Cortex16(4), 537–540 (2006).
  • Garcia-Larrea L, Convers P, Magnin M et al. Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain. Brain125(Pt 12), 2766–2781 (2002).
  • Hall SD, Hillebrand A, Furlong PL, Seri S, Barnes GR. Pharmaco-MEG: the cortical oscillatory profile of benzodiazepine uptake. Presented at: 15th International Conference on Biomagnetism A3709 20–26 August 2006.
  • Stern J, Jeanmonod D, Sarnthein J. Persistent EEG overactivation in the cortical pain matrix of neurogenic pain patients. Neuroimage31(2), 721–731 (2006).
  • Hobson AR, Aziz Q. Central nervous system processing of human visceral pain in health and disease. News Physiol. Sci.18, 109–114 (2003).
  • Hobson AR, Sarkar S, Furlong PL, Thompson DG, Aziz Q. A cortical evoked potential study of afferents mediating human esophageal sensation. Am. J. Physiol. Gastrointest. Liver Physiol.279(1), G139–G147 (2000).
  • Sarkar S, Hobson AR, Furlong PL et al. Central neural mechanisms mediating human visceral hypersensitivity. Am. J. Physiol. Gastrointest. Liver Physiol.281(5), G1196–G1202 (2001).
  • Hobson AR, Furlong PL, Sarkar S et al. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology130(1), 80–88 (2006).
  • Hobson AR, Furlong PL, Worthen SF et al. Real-time imaging of human cortical activity evoked by painful esophageal stimulation. Gastroenterology128(3), 610–619 (2005).
  • Ploner M, Schmitz F, Freund HJ, Schnitzler A. Parallel activation of primary and secondary somatosensory cortices in human pain processing. J. Neurophysiol.81(6), 3100–3104 (1999).
  • Apkarian AV, Sosa Y, Sonty S et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J. Neurosci.24(46), 10410–10415 (2004).
  • Kuchinad A, Schweinhardt P, Seminowicz D et al. Accelerated brain gray-matter loss in fibromyalgia patients: premature aging of the brain? J. Neurosci.27(15) 4004–4007 (2007).
  • Jones AK, Watabe H, Cunningham VJ, Jones T. Cerebral decreases in opioid receptor binding in patients with central neuropathic pain measured by [11C]diprenorphine binding and PET. Eur. J. Pain8(5), 479–485 (2004).
  • Ravert HT, Bencherif B, Madar I, Frost JJ. PET imaging of opioid receptors in pain: progress and new directions. Curr. Pharm. Des.10(7), 759–768 (2004).
  • Wood PB, Bushnell MC, Dagher A et al. Disruption of dopaminergic reactivity in fibromyalgia demonstrated by [11C]-raclopride/PET. Eur. J. Pain10(Suppl. 1), S115 (2006).
  • Martikainen IK, Hagelberg N, Mansikka H et al. Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesia. Neurosci. Lett.376(3), 149–153 (2005).
  • Hagelberg N, Jaaskelainen SK, Martikainen IK et al. Striatal dopamine D2 receptors in modulation of pain in humans: a review. Eur. J. Pharmacol.500(1–3), 187–192 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.